輔酶 Q10 (輔酵素 Q10) Coenzyme Q10 × 心臟衰竭
結論：證據支持但有警示
PubMed 層級證據相對紮實：2024 年大型統合分析（33 RCT、3,763 受試者）顯示輔酶 Q10 降低全因死亡率、住院率並改善 LVEF 與 6 分鐘步行距離，2021 年 Cochrane 也結論「可能降低死亡率」。
B 🟡 B 初步證據 附警語發布 🚨 high — heavy affiliate marketing in TW community
PubMed 層級證據相對紮實：2024 年大型統合分析（33 RCT、3,763 受試者）顯示輔酶 Q10 降低全因死亡率、住院率並改善 LVEF 與 6 分鐘步行距離，2021 年 Cochrane 也結論「可能降低死亡率」。
然而證據強度不到 A 級，原因有三：(1) Cochrane 對 LVEF 證據評為「極低品質」；(2) 各 RCT 劑量差異極大（30–400 mg/day），最佳劑量未確立；(3) Q-SYMBIO 試驗存在收案速度緩慢等方法學爭議。
整體屬於「中等品質、多個 MA 收斂但仍需更大型試驗確認」的 B 級。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.61
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
83%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧／統合分析
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.607
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (4 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Coenzyme Q10 for heart failure
結論：CoQ10 probably reduces all-cause mortality (RR 0.58, 95% CI 0.35-0.95, moderate-quality) and HF hospitalisation (RR 0.62, 95% CI 0.49-0.78, moderate-quality), but LVEF improvement is inconclusive (MD 1.77, 95% CI 0.09-3.44, very-low-quality) and authors conclude there is no convincing evidence to support or refute use.
前往 PubMed The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial
結論：In the Q-SYMBIO multicentre double-blind RCT, CoQ10 100 mg three times daily halved 2-year MACE (15% vs 26%; HR 0.50, 95% CI 0.32-0.80, p=0.003) and reduced all-cause mortality (10% vs 18%, p=0.018).
前往 PubMed Effect of coenzyme Q10 on cardiac function and survival in heart failure: an overview of systematic reviews and meta-analyses
結論：Umbrella review of 10 meta-analyses found CoQ10 reduced mortality (RR range 0.69 [0.50-0.95] to 0.58 [0.35-0.95]) and hospitalisation (RR 0.62, 95% CI 0.49-0.78) and improved LVEF in 6 of 9 studies (+1.77% to +3.81%), but did NOT improve exercise capacity.
前往 PubMed Evaluating the efficacy of ubiquinol in heart failure patients: a systematic review and meta-analysis
結論：Across 16 studies, ubiquinol/CoQ10 reduced HF-related mortality by 40% and improved exercise capacity, but showed NO significant difference in LVEF; the abstract reports no 95% CI or p-value for the headline mortality figure.
前往 PubMed Coenzyme Q10 in the treatment of heart failure: A systematic review of systematic reviews
結論：Overview of 7 systematic reviews (covering ~71 RCTs, ~4,688 participants) concluded there is a case for CoQ10 as ADJUNCTIVE therapy in congestive heart failure, especially for patients unable to tolerate mainstream therapy; no pooled effect size is given in the abstract.
前往 PubMed L4a US FDA
謹慎
not generally recognized as safe and effective for the referenced uses and therefore are considered "new drugs" 來源↗
L4b EU EFSA
反對
a cause and effect relationship has not been established between the consumption of coenzyme Q10 and the claimed effects 來源↗
L4c UK NHS
謹慎
Advise people with migraine that the food supplement riboflavin (400 mg once a day) may be effective in reducing migraine frequency and intensity for some people. 來源↗
L4d TW TFDA / 衛福部
謹慎
訂定「食品原料輔酵素Q10 (Coenzyme Q10)之使用限制及標示規定」 來源↗
L4e WHO
未表態
— 本適應症無對應資料
L5a NIH Office of Dietary Supplements
謹慎
— 本適應症無對應資料
L5b Mayo Clinic
謹慎
CoQ10 may improve congestive heart failure symptoms. Additionally, although findings are mixed, CoQ10 might help lower blood pressure. Some research also suggests that when taken with other nutrients, CoQ10 might help people recover from bypass and heart valve surgeries. Most healthcare professionals think CoQ10 is safe, with few side effects, but ask your healthcare professional before you tak… 來源↗
L5c Cleveland Clinic
謹慎
CoQ10 may benefit people living with heart disease — particularly heart failure. CoQ10 supplementation is in addition to other treatments you're undergoing. It's meant to work with what you're already doing, not replace it. 來源↗
L5d Harvard Health
謹慎
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
反對
The American College of Cardiology Foundation and the American Heart Association recommended against the use of nutritional supplements (including coenzyme Q10) for the treatment of heart failure. 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 極高
低中高
📍立場總覽
TW 社群（PTT 藥版、Mobile01、Dcard）普遍將 Q10 視為心臟衰竭的「輔助療法」而非治療藥物，多數網友（含藥師）態度偏謹慎正面：認可粒線體 ATP 機制與日本早期研究，但強調必須先諮詢心臟科醫師、留意與抗凝血藥的交互作用，並提醒「不能單靠 Q10 治療心衰竭」。
💬社群實感
意見分歧
破解迷思 社群最常見的 5 個誤解
✓
事實誤以為 Q10 可單獨治療或取代心臟衰竭處方藥
✓
事實氧化型與還原型（ubiquinol）功效相同（實際還原型吸收較佳）
✓
事實劑量越高越有效（社群常推到 600-900 mg，但台灣法規僅 30 mg/粒）
✓
事實Q10 完全沒有副作用、與任何藥物都不衝突（忽略與抗凝血藥交互作用）
✓
事實日本免稅店買的 Q10 一定比較好、可以當藥用
🩹 社群通報的副作用
- 與抗凝血藥（warfarin）併用可能增加出血風險
- 與降血壓藥併用可能血壓過低
- 少數人腸胃不適
- 睡前服用可能影響睡眠（部分網友提到較有精神）
🏷️ 社群熱議品牌
依論壇被提及頻率，非銷售或品質排序。
- GNC
- DHC
- 日本味王
- LAC 利維喜（納豆激酶+Q10）
- Doctor's Best
- 21st Century
- 安麗 Amway
⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。
- GDMT 四柱治療
- 心臟復健
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-heart-failure-INT-coenzyme-q10-001/",
"datePublished": "2026-06-09",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "輔酶 Q10 (輔酵素 Q10)能改善心臟衰竭",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}